0001127602-21-010492.txt : 20210312 0001127602-21-010492.hdr.sgml : 20210312 20210312215953 ACCESSION NUMBER: 0001127602-21-010492 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210310 FILED AS OF DATE: 20210312 DATE AS OF CHANGE: 20210312 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: O'Day Daniel Patrick CENTRAL INDEX KEY: 0001638643 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19731 FILM NUMBER: 21739640 MAIL ADDRESS: STREET 1: 333 LAKESIDE DRIVE CITY: FOSTER CITY STATE: CA ZIP: 94404 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GILEAD SCIENCES INC CENTRAL INDEX KEY: 0000882095 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943047598 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 6505743000 MAIL ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2021-03-10 0000882095 GILEAD SCIENCES INC GILD 0001638643 O'Day Daniel Patrick 333 LAKESIDE DRIVE FOSTER CITY CA 94404 1 1 Chairman & CEO Common Stock 2021-03-10 4 M 0 10800 A 147136 D Common Stock 2021-03-10 4 F 0 5123 63.91 D 142013 D Restricted Stock Unit 2021-03-10 4 A 0 52810 A Common Stock 52810 161656 D Non-qualified Stock Option (Right to Buy) 63.91 2021-03-10 4 A 0 307355 63.91 A 2021-03-12 Common Stock 307355 307355 D Restricted Stock Unit 2021-03-10 4 M 0 10800 D Common Stock 10800 150856 D Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. The shares subject to the option have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. The options have a four-year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. /s/ Amy Kim by Power of Attorney for Daniel O'Day 2021-03-12